(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

Teva Pharmaceutical Industries ( TEVA +20.23%) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

For its third quarter, Crinetics earned $143,000 in revenue, derived fully from a licensing agreement with Japanese ...

Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.47. ARS Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, ...

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

Learn more about whether ADMA Biologics, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ ...

On November 3, 2025, Privium Fund Management B.V. reported selling 138,263 shares of Arrowhead Pharmaceuticals ( ARWR 1.57%) ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid guidance for 2025.

Indian drugmaker Torrent Pharma reported a 30.5% rise in its second-quarter profit on Friday, driven by strong domestic demand for its cardiovascular and anti-diabetic drugs.

Skyrocketing healthcare costs could deliver another blow to the industry’s ongoing quest to boost representation in R&D.

Learn more about whether BioMarin Pharmaceutical Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...